GAMMA Investing’s Oric Pharmaceuticals ORIC Stock Holding History

GAMMA Investing’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9.23K	Buy	685 +351	+105%	+$4.37K	﹤0.01%	3387
2026 Q2	$3.62K	Sell	334 -218	-39%	-$1.98K	﹤0.01%	3602
2026 Q1	$6.99K	Buy	552 +49	+10%	+$556	﹤0.01%	3232
2025 Q4	$4.12K	Buy	503 +93	+23%	+$1.07K	﹤0.01%	3363
2025 Q3	$4.92K	Buy	410 +74	+22%	+$779	﹤0.01%	3191
2025 Q2	$3.41K	Sell	336 -371	-52%	-$2.49K	﹤0.01%	3252
2025 Q1	$3.94K	Buy	707 +558	+374%	+$4.88K	﹤0.01%	3179
2024 Q4	$1.2K	Buy	149 +106	+247%	+$973	﹤0.01%	3369
2024 Q3	$441	Sell	43 -36	-46%	-$356	﹤0.01%	3411
2024 Q2	$559	Buy	79 +49	+163%	+$439	﹤0.01%	3192
2024 Q1	$413	Buy	+30	New	+$356	﹤0.01%	3133

Other funds holding ORIC

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's ORIC Position: Q3 2026 in Review

GAMMA Investing increased its Oric Pharmaceuticals (ORIC) stake by 105% in Q3 2026, buying an estimated $4.37K and bringing the position to 685 shares worth $9.23K. The position accounts for ﹤0.01% of the portfolio, ranked #3387.

GAMMA Investing first reported a position in ORIC in Q1 2024 and has held it in 11 quarters since. 3 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.

GAMMA Investing held 685 shares of Oric Pharmaceuticals worth $9.23K as of Q3 2026.
GAMMA Investing bought 351 Oric Pharmaceuticals shares in Q3 2026, an estimated $4.37K.
Oric Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3387 holding.
GAMMA Investing first reported a position in Oric Pharmaceuticals in Q1 2024 and has held it in 11 quarters since.
3 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.